U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
149641149641Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaActive, not recruitingHas ResultsLeukemia|LymphomaBiological: Rituximab|Drug: Cyclophosphamide|Drug: Lenalidomide|Drug: Pentostatinhttps://ClinicalTrials.gov/show/NCT00602836
149642149642Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)CompletedNo Results AvailablePsoriasishttps://ClinicalTrials.gov/show/NCT00602823
149643149643Vinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung CancerRecruitingNo Results AvailableRecurrent Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung CancerDrug: vinorelbine tartrate|Drug: paclitaxel|Procedure: quality-of-life assessment|Other: questionnaire administrationhttps://ClinicalTrials.gov/show/NCT00602797
149644149644Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide VaccineCompletedNo Results AvailableChronic Hepatitis CBiological: IC41https://ClinicalTrials.gov/show/NCT00602784
149645149645Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid LeukemiaCompletedHas ResultsAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic LeukemDrug: tipifarnib|Drug: etoposidehttps://ClinicalTrials.gov/show/NCT00602771
149646149646Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIVCompletedNo Results AvailableHIV Infections|Acquired Immunodeficiency SyndromeBehavioral: Motivational interviewing with cognitive behavioral therapy|Behavioral: Modified directly observed therapyhttps://ClinicalTrials.gov/show/NCT00602758
149647149647S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based RegimenTerminatedNo Results AvailablePancreatic Neoplasm|Neoplasm MetastasisDrug: S-1|Drug: 5-Fluorouracilhttps://ClinicalTrials.gov/show/NCT00602745
149648149648Interpersonal Treatment Program to Prevent Depression and Post-Traumatic Stress Disorder in Low-Income Pregnant Women With Partner AbuseCompletedNo Results AvailableDepression, Postpartum|DepressionBehavioral: The Reach Out for a Safe Environment (ROSE) program|Behavioral: Enhanced care as usual (ECU)https://ClinicalTrials.gov/show/NCT00602732
149649149649Bioequivalency Study of Zolpidem Tartrate Under Fed ConditionsCompletedNo Results AvailableInsomniaDrug: Zolpidemhttps://ClinicalTrials.gov/show/NCT00602719
149650149650Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell TransplantCompletedNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmBiological: sargramostim|Drug: melphalan|Procedure: autologous hematopoietic stem cell transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: samarium Sm 153 lexidronam pentasodiumhttps://ClinicalTrials.gov/show/NCT00602706
149651149651T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic CancerActive, not recruitingNo Results AvailableLeukemia|Lymphoma|Multiple Myeloma|Plasma Cell Neoplasm|Myelodysplastic SyndromesBiological: umbilical cord blood transplantation|Drug: Allopurinol|Drug: fludarabine phosphate|Drug: Cyclophosphamide|Radiation: Total body irradiation|Biological: Treg infusion|Drug: Sirolimushttps://ClinicalTrials.gov/show/NCT00602693
149652149652Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's DiseaseTerminatedNo Results AvailableAlzheimer's DiseaseDrug: SSR180711C|Drug: donepezil|Drug: placebohttps://ClinicalTrials.gov/show/NCT00602680
149653149653Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or EpendymomaRecruitingNo Results AvailableBrain and Central Nervous System TumorsDrug: Induction Chemotherapy|Drug: Low-Risk Therapy|Drug: High-Risk Therapy|Drug: Intermediate-Risk Therapyhttps://ClinicalTrials.gov/show/NCT00602667
149654149654Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaActive, not recruitingHas ResultsStage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple MyelomaDrug: melphalan|Drug: prednisone|Drug: thalidomide|Drug: lenalidomidehttps://ClinicalTrials.gov/show/NCT00602641
149655149655Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the BreastCompletedNo Results AvailableBreast CancerOther: questionnaire administration|Procedure: adjuvant therapy|Procedure: biopsy|Procedure: computed tomography|Procedure: dynamic contrast-enhanced magnetic resonance imaging|Procedure: magnetic resonance imaging|Procedure: therapeutic conventional surgery|Procedure: ultrasound imaging|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00602628
149656149656Bioequivalency Study of Torsemide Tablets Under Fed ConditionsCompletedNo Results AvailableEdemaDrug: Torsemidehttps://ClinicalTrials.gov/show/NCT00602615
149657149657Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic CancerRecruitingNo Results AvailablePancreatic CancerBiological: bevacizumab|Drug: fluorouracil|Drug: gemcitabine hydrochloride|Drug: oxaliplatin|Other: immunohistochemistry staining method|Other: laboratory biomarker analysis|Procedure: conventional surgery|Procedure: endoscopic biopsy|Procedure: laparoscopy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00602602
149658149658A Study to Evaluate the Bioequivalence of an Oral Suspension Formulation, an Oral Solution Formulation, and the Marketed Tablet Formulation of Levofloxacin in Healthy SubjectsCompletedNo Results AvailableThe Focus of the Study is to Determine the Bioequivalence of Three Formulations of Levofloxacin.Drug: Levofloxacin oral suspension; Levofloxacin oral solution; and Levofloxacin marketed tablet formulationshttps://ClinicalTrials.gov/show/NCT00602589
149659149659Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable MelanomaActive, not recruitingNo Results AvailableMelanoma (Skin)Drug: sorafenib tosylate|Drug: temozolomidehttps://ClinicalTrials.gov/show/NCT00602576
149660149660Attention Training for Generalized Anxiety DisorderRecruitingNo Results AvailableGeneralized Anxiety DisorderBehavioral: AMP|Behavioral: Applied Relaxation (AR)|Behavioral: Clinical Monitoring (CM)|Behavioral: Combining the AMP and ARhttps://ClinicalTrials.gov/show/NCT00602563
149661149661Bioequivalency Study of Zidovudine Under Fasting ConditionsCompletedNo Results AvailableHIV InfectionsDrug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00602550
149662149662Antidepressant Therapy in Treating Bipolar Type II Major DepressionCompletedNo Results AvailableBipolar Disorder|DepressionDrug: Venlafaxine|Drug: Lithium Carbonatehttps://ClinicalTrials.gov/show/NCT00602537
149663149663Bioequivalency Study of 7.5 mg Pilocarpine Tablets Under Fasting ConditionsCompletedNo Results AvailableDry MouthDrug: Pilocarpinehttps://ClinicalTrials.gov/show/NCT00602524
149664149664Thalidomide Versus Bortezomib in Melphalan Refractory MyelomaCompletedNo Results AvailableMultiple MyelomaDrug: Bortezomib|Drug: Thalidomidehttps://ClinicalTrials.gov/show/NCT00602511
149665149665Bioequivalency Study of Clarithromycin Tablets Under Fed ConditionsCompletedNo Results AvailableInfectionDrug: Clarithromycinhttps://ClinicalTrials.gov/show/NCT00602498
149666149666The Effect of Action Control Based Intervention on Adherence After Cardiac RehabilitaitonCompletedNo Results AvailableHeart FailureOther: Action Control Educationhttps://ClinicalTrials.gov/show/NCT00602485
149667149667BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 DiabetesCompletedHas ResultsDiabetes Mellitus, Type 2Drug: linagliptin|Drug: placebohttps://ClinicalTrials.gov/show/NCT00602472
149668149668Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic LeukemiaActive, not recruitingNo Results AvailableChronic Lymphocytic Leukemia|Stage I Chronic Lymphocytic Leukemia|Stage II Chronic Lymphocytic Leukemia|Stage III Chronic Lymphocytic Leukemia|Stage IV Chronic Lymphocytic LeukemiaDrug: Cyclophosphamide|Drug: Fludarabine Phosphate|Other: Laboratory Biomarker Analysis|Drug: Lenalidomide|Biological: Rituximabhttps://ClinicalTrials.gov/show/NCT00602459
149669149669Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell TransplantTerminatedHas ResultsBreast Cancer|Iron Overload|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Neuroblastoma|Ovarian CancerDrug: deferasiroxhttps://ClinicalTrials.gov/show/NCT00602446
149670149670Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving ErlotinibCompletedNo Results AvailableAdvanced Nonsmall Cell Lung Cancerhttps://ClinicalTrials.gov/show/NCT00602433

* Görseller ve İçerik tekif hakkına sahip olabilir